1. Stocks
  2. Novartis AG - ADR
  3. Swot
swot-logo

Novartis AG - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Novartis AG - ADR has 21 Strengths, 3 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Stocks with strong dividend yields in FY25 and healthy growth over 5 years

High Normalized Momentum Score

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

New 52 week high today

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Increasing Revenue every Quarter for the past 4 Quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Increasing profits every quarter for the past 2 quarters

Top Gainers

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

Declining Net Cash Flow : Companies not able to generate net cash

Companies Increasing Debt as per Annual Report

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Institutions decreased their shareholding last quarter

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks